Xiaozhi Yang

531 total citations
18 papers, 361 citations indexed

About

Xiaozhi Yang is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Xiaozhi Yang has authored 18 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Organic Chemistry. Recurrent topics in Xiaozhi Yang's work include Cancer-related gene regulation (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Cancer Mechanisms and Therapy (2 papers). Xiaozhi Yang is often cited by papers focused on Cancer-related gene regulation (3 papers), Cytokine Signaling Pathways and Interactions (3 papers) and Cancer Mechanisms and Therapy (2 papers). Xiaozhi Yang collaborates with scholars based in China, United States and Poland. Xiaozhi Yang's co-authors include Ian Krajbich, Lipeng Tang, Guangjuan Zheng, Chenglong Li, Yongxin Liang, Zhenhua Dai, Guoqing Gong, Yungen Xu, Guangwei He and Jaime Imitola and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Psychological Review.

In The Last Decade

Xiaozhi Yang

16 papers receiving 348 citations

Peers

Xiaozhi Yang

IMMUN

ONCOL

GENET

Carol W. Johnson United States

John A. Halsall United Kingdom

John Astle United States

Roberta Cariati Italy

Akie Maehara Japan

Wei-ping Zheng United States

Teneille Walker United States

Nadya Al‐Yacoub Saudi Arabia

Gudrun Scherer Germany

Carol W. Johnson United States

Xiaozhi Yang

141 ×0.9

42 ×0.5

IMMUN

64 ×0.8

ONCOL

20 ×0.4

19 ×0.6

GENET

Citations per year, relative to Xiaozhi Yang Xiaozhi Yang (= 1×) peers Carol W. Johnson

Countries citing papers authored by Xiaozhi Yang

Since Specialization

Citations

This map shows the geographic impact of Xiaozhi Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaozhi Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaozhi Yang more than expected).

Fields of papers citing papers by Xiaozhi Yang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaozhi Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaozhi Yang. The network helps show where Xiaozhi Yang may publish in the future.

Co-authorship network of co-authors of Xiaozhi Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaozhi Yang. A scholar is included among the top collaborators of Xiaozhi Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaozhi Yang. Xiaozhi Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Yang, Xiaozhi, Gustavo Seabra, Jiawei Dong, et al.. (2025). Discovery and Mechanism of 16–19F, a Novel Synthetic Lethal Inhibitor of the PRMT5•MTA Complex in MTAP-Deleted Cancer Cells. ACS Chemical Biology. 20(6). 1333–1346. 1 indexed citations

Yang, Xiaozhi, Chris Retzler, Ian Krajbich, Roger Ratcliff, & Marios G. Philiastides. (2024). Attention to brand labels affects, and is affected by, evaluations of product attractiveness. SHILAP Revista de lepidopterología. 2.

Yang, Jian, et al.. (2023). Research on MobileNet-based lightweight face recognition algorithm. 40–40.

Yang, Xiaozhi, et al.. (2022). Cryo-EM structure-based selection of computed ligand poses enables design of MTA-synergic PRMT5 inhibitors of better potency. Communications Biology. 5(1). 1054–1054. 5 indexed citations

Yang, Xiaozhi & Ian Krajbich. (2022). A dynamic computational model of gaze and choice in multi-attribute decisions.. Psychological Review. 130(1). 52–70. 31 indexed citations

Jiang, Jinmai, Kalina R. Atanasova, Gamze B. Bulut, et al.. (2022). Pharmacological inhibition and reversal of pancreatic acinar ductal metaplasia. Cell Death Discovery. 8(1). 378–378. 11 indexed citations

Yang, Xiaozhi, Jinhua Song, Wei Pei, et al.. (2021). A STAT3 inhibitor ameliorates CNS autoimmunity by restoring Teff:Treg Balance. JCI Insight. 6(4). 23 indexed citations

Chen, Xiang, Li Pan, Jia Wei, et al.. (2021). LLL12B, a small molecule STAT3 inhibitor, induces growth arrest, apoptosis, and enhances cisplatin-mediated cytotoxicity in medulloblastoma cells. Scientific Reports. 11(1). 6517–6517. 14 indexed citations

Zhang, Jiayu, Ying Liu, Jingyi Tan, et al.. (2021). Necroptotic virotherapy of oncolytic alphavirus M1 cooperated with Doxorubicin displays promising therapeutic efficacy in TNBC. Oncogene. 40(29). 4783–4795. 35 indexed citations

10.

Yang, Xiaozhi, et al.. (2021). A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin. PLoS ONE. 16(4). e0240145–e0240145. 11 indexed citations

11.

Yang, Xiaozhi & Ian Krajbich. (2020). Webcam-based online eye-tracking for behavioral research. PsyArXiv (OSF Preprints). 18 indexed citations

12.

Tang, Lipeng, et al.. (2019). Long non‐coding RNAs in cutaneous biology and proliferative skin diseases: Advances and perspectives. Cell Proliferation. 53(1). e12698–e12698. 39 indexed citations

13.

Tang, Lipeng, et al.. (2018). Transcription Factor Retinoid-Related Orphan Receptor γt: A Promising Target for the Treatment of Psoriasis. Frontiers in Immunology. 9. 51 indexed citations

14.

Banasavadi‐Siddegowda, Yeshavanth, Alessandra M. Welker, Min An, et al.. (2017). PRMT5 as a druggable target for glioblastoma therapy. Neuro-Oncology. 20(6). 753–763. 80 indexed citations

15.

Li, Yunzhan, Guoqing Gong, Xinhui Wang, et al.. (2013). Antithrombotic activity of HY023016, a novel Dabigatran prodrug evaluated in animal thrombosis models. Thrombosis Research. 131(5). 425–435. 9 indexed citations

16.

Yang, Xiaozhi, et al.. (2013). Design, synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing methyl ferulate. Bioorganic & Medicinal Chemistry Letters. 23(7). 2089–2092. 19 indexed citations

17.

Yang, Xiaozhi, et al.. (2012). Synthesis and antithrombotic evaluation of novel dabigatran prodrugs containing a cleavable moiety with anti-platelet activity. European Journal of Medicinal Chemistry. 57. 21–28. 13 indexed citations

18.

Yang, Yun, et al.. (2012). Synthesis and Bioactivity of Substituted Benzoylguanidine Derivatives as Potent Na⁺/H⁺ Exchanger Inhibitors. Chinese Journal of Chemistry. 30(2). 333–340. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact